Preparation and Characterization of Nickel Nanoparticles for Binding to His-tag Proteins and Antigens
- 19 December 2006
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 24 (2) , 343-352
- https://doi.org/10.1007/s11095-006-9154-7
Abstract
The purpose of these studies was to prepare nanoparticles (NPs) with a small amount of surface-chelated nickel for obtaining enhanced binding of histidine-tagged (his-tag) proteins compared to non-histidine-tagged protein binding to charged nanoparticles. NPs were prepared from oil-in-water microemulsion precursors using emulsifying wax, 3 mM Brij 78 and 0.1 mM DOGS–NTA–Ni lipid (referred to as Ni-NPs). The amount of lipid entrapped in the NPs was quantitated by atomic emission spectroscopy (AES). The Ni-NPs were investigated for binding to two his-tag proteins, green fluorescent protein (GFP) and his-tag HIV-1 Gag p24. In vivo studies in mice were carried out to evaluate the immune responses obtained to his-tag Gag p24 bound to Ni-NPs. AES studies demonstrated that approximately 5% of the DOGS–NTA–Ni lipid used was entrapped in the NPs. The optimal binding ratio his-tag GFP and his-tag Gag p24 to Ni-NPs was found to be 1:33.7 and 1:35.4 w/w, respectively. This interaction was stable at 37°C in PBS, pH 7.4 over 4 h and the interaction of his-tag GFP with the Ni-NPs was enhanced compared to control NPs prepared with no Ni on the surface (NTA-NPs). The in vivo studies demonstrated enhanced serum IgG and IgG2a responses to his-tag Gag p24 bound to Ni-NPs compared to protein adjuvanted with Alum or adsorbed on the surface of control NTA-NPs. Ni-NPs can be used to bind strongly to his-tag proteins. This system was demonstrated to have potential applications in vaccine delivery for enhancing immune responses to protein-based vaccines.Keywords
This publication has 51 references indexed in Scilit:
- HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvantVaccine, 2006
- Strong T cell type-1 immune responses to HIV-1 Tat (1–72) protein-coated nanoparticlesVaccine, 2004
- 4th Meeting on novel adjuvants currently in/close to human clinical testing: World Health Organization—Organisation Mondiale de la Santé Fondation Mérieux, Annecy, France, 23–25 June 2003Vaccine, 2004
- Charged polylactide co-glycolide microparticles as antigen delivery systemsExpert Opinion on Biological Therapy, 2004
- Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticlesVaccine, 2004
- Development and characterization of Ni‐NTA‐bearing microspheresCytometry, 2002
- Oligomannose-coated liposomes as an adjuvant for the induction of cell-mediated immunityFEBS Letters, 1995
- Affinity purification of histidine-tagged proteinsMolecular Biology Reports, 1993
- A new hydrophobic anchor for the attachment of proteins to liposomal membranesFEBS Letters, 1986
- Influence of cadmium, nickel, and chromium on primary immunity in miceEnvironmental Research, 1978